INKT Chart
See on advanced chart >
About
MiNK Therapeutics, Inc. was incorporated in Delaware in July 2017. The company is a clinical stage biopharmaceutical company pioneering the discovery, development and commercialization of allogeneic, off-the-shelf iNKT cell therapies to treat cancer and other...
Read More
- HighlightA biotechnology company focused on developing cancer immunotherapies and autoimmune disease treatments
- ExchangeNASDAQ
- Listing Date10/15/2021
- Established DateInvalid Date
- Full-time Employees31
- Address149 Fifth Avenue Suite 500 New York NY 10010
- Tel1-212-9948250
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology